Global Palonosetron Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Market Overview

• 1.1 Palonosetron Introduction
• 1.2 Market Analysis by Type
  • 1.2.1 Injection 0.25 mg/5 mL
  • 1.2.2 Injection 20 mcg/kg (max 1.5 mg)
• 1.3 Market Analysis by Applications
  • 1.3.1 Adults
  • 1.3.2 Children
• 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
    • 1.4.1.1 United States Market States and Outlook (2013-2023)
    • 1.4.1.2 Canada Market States and Outlook (2013-2023)
    • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
    • 1.4.2.1 Germany Market States and Outlook (2013-2023)
    • 1.4.2.2 France Market States and Outlook (2013-2023)
    • 1.4.2.3 UK Market States and Outlook (2013-2023)
    • 1.4.2.4 Russia Market States and Outlook (2013-2023)
    • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    • 1.4.3.1 China Market States and Outlook (2013-2023)
    • 1.4.3.2 Japan Market States and Outlook (2013-2023)
    • 1.4.3.3 Korea Market States and Outlook (2013-2023)
    • 1.4.3.4 India Market States and Outlook (2013-2023)
    • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
    • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
    • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
    • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
    • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
• 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force

2 Manufacturers Profiles

• 2.1 Helsinn Therapeutics
  • 2.1.1 Business Overview
  • 2.1.2 Palonosetron Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Helsinn Therapeutics Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.2 Teva
  • 2.2.1 Business Overview
  • 2.2.2 Palonosetron Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Teva Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.3 Dr. Reddys Laboratories
  • 2.3.1 Business Overview
  • 2.3.2 Palonosetron Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Dr. Reddys Laboratories Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.4 Cipla
  • 2.4.1 Business Overview
  • 2.4.2 Palonosetron Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Cipla Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.5 Pfizer
  • 2.5.1 Business Overview
  • 2.5.2 Palonosetron Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Pfizer Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.6 Sandoz
  • 2.6.1 Business Overview
  • 2.6.2 Palonosetron Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 Sandoz Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.7 Aurobindo
  • 2.7.1 Business Overview
  • 2.7.2 Palonosetron Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Aurobindo Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.8 Sagent Pharmaceuticals
  • 2.8.1 Business Overview
  • 2.8.2 Palonosetron Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Sagent Pharmaceuticals Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.9 Fresenius Kabi
  • 2.9.1 Business Overview
  • 2.9.2 Palonosetron Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 Fresenius Kabi Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.10 Qilu Pharmaceutical
  • 2.10.1 Business Overview
  • 2.10.2 Palonosetron Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Qilu Pharmaceutical Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.11 Jiangsu Aosaikang Pharmaceutical
  • 2.11.1 Business Overview
  • 2.11.2 Palonosetron Type and Applications
    • 2.11.2.1 Product A
    • 2.11.2.2 Product B
  • 2.11.3 Jiangsu Aosaikang Pharmaceutical Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.12 Sichuan Hairong Pharmaceutical
  • 2.12.1 Business Overview
  • 2.12.2 Palonosetron Type and Applications
    • 2.12.2.1 Product A
    • 2.12.2.2 Product B
  • 2.12.3 Sichuan Hairong Pharmaceutical Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
• 2.13 Exela Pharma
  • 2.13.1 Business Overview
  • 2.13.2 Palonosetron Type and Applications
    • 2.13.2.1 Product A
    • 2.13.2.2 Product B
  • 2.13.3 Exela Pharma Palonosetron Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Palonosetron Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

• 3.1 Global Palonosetron Sales and Market Share by Manufacturer (2016-2017)
• 3.2 Global Palonosetron Revenue and Market Share by Manufacturer (2016-2017)
• 3.3 Market Concentration Rate
  • 3.3.1 Top 3 Palonosetron Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Palonosetron Manufacturer Market Share in 2017
• 3.4 Market Competition Trend

4 Global Palonosetron Market Analysis by Regions

• 4.1 Global Palonosetron Sales, Revenue and Market Share by Regions
  • 4.1.1 Global Palonosetron Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Palonosetron Revenue and Market Share by Regions (2013-2018)
• 4.2 North America Palonosetron Sales and Growth Rate (2013-2018)
• 4.3 Europe Palonosetron Sales and Growth Rate (2013-2018)
• 4.4 Asia-Pacific Palonosetron Sales and Growth Rate (2013-2018)
• 4.5 South America Palonosetron Sales and Growth Rate (2013-2018)
• 4.6 Middle East and Africa Palonosetron Sales and Growth Rate (2013-2018)

5 North America Palonosetron by Countries

• 5.1 North America Palonosetron Sales, Revenue and Market Share by Countries
  • 5.1.1 North America Palonosetron Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Palonosetron Revenue and Market Share by Countries (2013-2018)
• 5.2 United States Palonosetron Sales and Growth Rate (2013-2018)
• 5.3 Canada Palonosetron Sales and Growth Rate (2013-2018)
• 5.4 Mexico Palonosetron Sales and Growth Rate (2013-2018)

6 Europe Palonosetron by Countries

• 6.1 Europe Palonosetron Sales, Revenue and Market Share by Countries
  • 6.1.1 Europe Palonosetron Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Palonosetron Revenue and Market Share by Countries (2013-2018)
• 6.2 Germany Palonosetron Sales and Growth Rate (2013-2018)
• 6.3 UK Palonosetron Sales and Growth Rate (2013-2018)
• 6.4 France Palonosetron Sales and Growth Rate (2013-2018)
• 6.5 Russia Palonosetron Sales and Growth Rate (2013-2018)
• 6.6 Italy Palonosetron Sales and Growth Rate (2013-2018)

7 Asia-Pacific Palonosetron by Countries

• 7.1 Asia-Pacific Palonosetron Sales, Revenue and Market Share by Countries
  • 7.1.1 Asia-Pacific Palonosetron Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Palonosetron Revenue and Market Share by Countries (2013-2018)
• 7.2 China Palonosetron Sales and Growth Rate (2013-2018)
• 7.3 Japan Palonosetron Sales and Growth Rate (2013-2018)
• 7.4 Korea Palonosetron Sales and Growth Rate (2013-2018)
• 7.5 India Palonosetron Sales and Growth Rate (2013-2018)
• 7.6 Southeast Asia Palonosetron Sales and Growth Rate (2013-2018)

8 South America Palonosetron by Countries

• 8.1 South America Palonosetron Sales, Revenue and Market Share by Countries
  • 8.1.1 South America Palonosetron Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Palonosetron Revenue and Market Share by Countries (2013-2018)
• 8.2 Brazil Palonosetron Sales and Growth Rate (2013-2018)
• 8.3 Argentina Palonosetron Sales and Growth Rate (2013-2018)
• 8.4 Colombia Palonosetron Sales and Growth Rate (2013-2018)

9 Middle East and Africa Palonosetron by Countries

• 9.1 Middle East and Africa Palonosetron Sales, Revenue and Market Share by Countries
  • 9.1.1 Middle East and Africa Palonosetron Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Palonosetron Revenue and Market Share by Countries (2013-2018)
• 9.2 Saudi Arabia Palonosetron Sales and Growth Rate (2013-2018)
• 9.3 UAE Palonosetron Sales and Growth Rate (2013-2018)
• 9.4 Egypt Palonosetron Sales and Growth Rate (2013-2018)
• 9.5 Nigeria Palonosetron Sales and Growth Rate (2013-2018)
• 9.6 South Africa Palonosetron Sales and Growth Rate (2013-2018)

10 Global Palonosetron Market Segment by Type

• 10.1 Global Palonosetron Sales, Revenue and Market Share by Type (2013-2018)
  • 10.1.1 Global Palonosetron Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Palonosetron Revenue and Market Share by Type (2013-2018)
• 10.2 Injection 0.25 mg/5 mL Sales Growth and Price
  • 10.2.1 Global Injection 0.25 mg/5 mL Sales Growth (2013-2018)
  • 10.2.2 Global Injection 0.25 mg/5 mL Price (2013-2018)
• 10.3 Injection 20 mcg/kg (max 1.5 mg) Sales Growth and Price
  • 10.3.1 Global Injection 20 mcg/kg (max 1.5 mg) Sales Growth (2013-2018)
  • 10.3.2 Global Injection 20 mcg/kg (max 1.5 mg) Price (2013-2018)

11 Global Palonosetron Market Segment by Application

• 11.1 Global Palonosetron Sales Market Share by Application (2013-2018)
• 11.2 Adults Sales Growth (2013-2018)
• 11.3 Children Sales Growth (2013-2018)

12 Palonosetron Market Forecast (2018-2023)

• 12.1 Global Palonosetron Sales, Revenue and Growth Rate (2018-2023)
• 12.2 Palonosetron Market Forecast by Regions (2018-2023)
  • 12.2.1 North America Palonosetron Market Forecast (2018-2023)
  • 12.2.2 Europe Palonosetron Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Palonosetron Market Forecast (2018-2023)
  • 12.2.4 South America Palonosetron Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Palonosetron Market Forecast (2018-2023)
• 12.3 Palonosetron Market Forecast by Type (2018-2023)
  • 12.3.1 Global Palonosetron Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Palonosetron Market Share Forecast by Type (2018-2023)
• 12.4 Palonosetron Market Forecast by Application (2018-2023)
  • 12.4.1 Global Palonosetron Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Palonosetron Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

• 13.1 Sales Channel
  • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
• 13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

• 15.1 Methodology